Skip to main content

Columbia Banking Sys(COLB-Q)
NASDAQ

Today's Change
Real-Time Last Update Last Sale Cboe BZX Real-Time

SHAREHOLDER INVESTIGATION: Halper Sadeh LLP Investigates FLXN, AZPN, COLB, LMRK; Shareholders are Encouraged to Contact the Firm

PR Newswire - Wed Oct 20, 2021

NEW YORK, Oct. 20, 2021 /PRNewswire/ -- Halper Sadeh LLP, a global investor rights law firm, announces it is investigating the following companies:

Flexion Therapeutics, Inc. (NASDAQ: FLXN) concerning potential violations of the federal securities laws and/or breaches of fiduciary duties relating to its sale to Pacira BioSciences, Inc. for $8.50 per share in cash plus one non-tradeable contingent value right worth up to $8.00 per share in cash. If you are a Flexion shareholder, click here to learn more about your rights and options.

Read more at prnewswire.com

Provided Content: Content provided by PR Newswire. The Globe and Mail was not involved, and material was not reviewed prior to publication.

More from The Globe